FDA Brief

Warning letters Food

FDA warning letter to

Maruhachi Muramatsu Inc., Danchi Factory

High riskIssued Oct 17, 2024Posted Nov 26, 2024Human Foods Program

FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.

What happened

FDA inspected the seafood processing facility on April 23 and 24, 2024, and issued a Form FDA-483 (inspection observations list). FDA found the firm's HACCP (food safety control plan) for refrigerated reduced oxygen packaged (ROP) Noko Dashi Katsuo soup base did not meet the seafood HACCP regulation. FDA reviewed the firm's May 10, 2024 response and revised HACCP plan and found them inadequate.

What FDA found

  1. The plan's critical limits (the values that must be met at control points) for thermal processing were not adequate to control survival of pathogens such as non-proteolytic Clostridium botulinum type B.

    21 CFR 123.6(c)(3)
  2. The plan's critical limits for cooling were not adequate to control growth and toxin formation by spore-forming pathogens such as proteolytic C. botulinum and Bacillus cereus.

    21 CFR 123.6(c)(3)
  3. The plan did not list a critical control point (CCP) for filling the thermally processed soup into ROP bags to prevent recontamination, including at a product temperature of 85°C as it enters the final container.

    21 CFR 123.6(a) and (c)(2)
  4. The plan did not list a CCP for finished product cooling to control pathogen growth and toxin formation, including continuous cooler air temperature monitoring with at least a daily visual check of recorded data.

    21 CFR 123.6(a) and (c)(2)
  5. The plan's monitoring frequency for allergens not declared on labels was not adequate; it should be at least every two hours or when new labels are used in addition to before manufacturing.

    21 CFR 123.6(c)(4)
  6. The plan's corrective actions (steps taken when a limit is missed) at several CCPs were not adequate, such as not including repairing or adjusting equipment, discarding affected product, or removing inaccurate labels and discontinuing use of a supplier until corrections are made.

    21 CFR 123.7(b)

What FDA wants

FDA tells the company to respond in writing within 15 working days with specific corrections, including a revised hazard analysis and HACCP plan and five consecutive days of completed monitoring records for five production date codes. If corrections cannot be completed within 15 days, the company must explain the delay and state when remaining violations will be corrected.

Who should pay attention

  • U.S. importers of Japanese seafood soups
  • retailers and distributors selling refrigerated seafood products
  • contract manufacturers using similar seafood HACCP plans

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Ocean Pride Seafood, Inc.

    FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.

    High risk
  2. Star Ocean Wholesale Foods, Inc.

    FDA warns Star Ocean Wholesale Foods over missing checks for imported fermented fish sauce.

    High risk
  3. South Asian Food Inc.

    South Asian Food Inc. lacked seafood HACCP import verification and pest controls for imported dried seafood.

    High risk
  4. AF Import & Wholesale Co

    FDA warned Houston seafood importer AF Import & Wholesale for missing written verification that its imported fish was processed safely.

    High risk